A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study

Acta Dermatovenerol Alp Pannonica Adriat. 2018 Jun;27(2):51-57.

Abstract

Introduction: Currently there are only a limited number of drugs available for treatment of androgenetic alopecia and telogen effluvium. However, certain plants and their standardized extracts may provide some clinical benefits against hair loss. We formulated a herbal shampoo and a solution to evaluate their efficacy, safety, and synergy in hair loss.

Methods: We conducted a randomized, placebo-controlled, single-blind, clinical and instrumental study for 6 months on 120 subjects with androgenetic alopecia and telogen effluvium, confirmed by pull test and phototricogram. Each subject was examined monthly. At the end of the study, a self-assessment test was carried out.

Results: Herbal formulations were found to be more effective in preventing and reducing hair loss than placebo at every assessment point. Anagen/telogen ratios improved significantly in the study group. In addition, concomitant use of the shampoo and solution were found to be more effective than single product use.

Conclusion: We interpret this eutrophic effect for scalp hair as the final outcome of the entire content of our herbal formula, which has antiandrogenic, anti-inflammatory, antioxidative, angiogenic, and hair-stimulating features. In combination, these features help prevent hair from falling out and reducing hair loss.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Alopecia / therapy*
  • Female
  • Hair Preparations / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Patient Outcome Assessment
  • Phytotherapy*
  • Plant Extracts / therapeutic use*
  • Single-Blind Method
  • Young Adult

Substances

  • Hair Preparations
  • Plant Extracts